Evidence map›Paper›PMID 37062021›Full record

ReviewAbdominal radiology (New York)2023

PET/MRI in colorectal and anal cancers: an update.

Vetri Sudar Jayaprakasam, Semra Ince, Garima Suman, Pankaj Nepal, Thomas A Hope, Raj Mohan Paspulati, Tyler J Fraum

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Diagnostic Performance of [World journal of nuclear medicine · 2025
    Review
  3. Review
  4. Article
  5. Medical Radiology: Current Progress.Diagnostics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Vetri Sudar JayaprakasamMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. jayaprav@mskcc.org.ORCID 0000-0002-7360-9867
Semra InceDepartment of Radiology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID 0000-0001-9633-052X
Garima SumanDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4875-3170
Pankaj NepalDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-6400-8915
Thomas A HopeDepartment of Radiology & Biomedical Imaging, University of California, San Francisco, CA, USA.ORCID 0000-0002-2228-5823
Raj Mohan PaspulatiDepartment of Radiology, Moffitt Cancer Center, Tampa, FL, USA.
Tyler J FraumDepartment of Radiology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID 0000-0001-6573-5081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Positron emission tomography (PET) in the era of personalized medicine has a unique role in the management of oncological patients and offers several advantages over standard anatomical imaging. However, the role of molecular imaging in lower GI malignancies has historically been limited due to suboptimal anatomical evaluation on the accompanying CT, as well as significant physiological

Indexed as

Anus NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsAnal cancerColon cancerFluorodeoxyglucose F18 (FDG)Hybrid ImagingMagnetic resonance imagingPET/MRIPositron-emission tomographyRectal cancer

Identifiers

PMID37062021

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.